232 related articles for article (PubMed ID: 27136531)
1. Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse.
Al-Temaimi RA; Tan TZ; Marafie MJ; Thiery JP; Quirke P; Al-Mulla F
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136531
[TBL] [Abstract][Full Text] [Related]
2. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
[TBL] [Abstract][Full Text] [Related]
3. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract][Full Text] [Related]
4. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
5. Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse.
Al-Mulla F; Behbehani AI; Bitar MS; Varadharaj G; Going JJ
Mod Pathol; 2006 May; 19(5):648-58. PubMed ID: 16528379
[TBL] [Abstract][Full Text] [Related]
6. Identification of chromosome aberrations in sporadic microsatellite stable and unstable colorectal cancers using array comparative genomic hybridization.
Dyrsø T; Li J; Wang K; Lindebjerg J; Kølvraa S; Bolund L; Jakobsen A; Bruun-Petersen G; Li S; Crüger DG
Cancer Genet; 2011 Feb; 204(2):84-95. PubMed ID: 21504706
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
8. Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.
Bruin SC; Klijn C; Liefers GJ; Braaf LM; Joosse SA; van Beers EH; Verwaal VJ; Morreau H; Wessels LF; van Velthuysen ML; Tollenaar RA; Van't Veer LJ
BMC Cancer; 2010 Dec; 10():662. PubMed ID: 21126340
[TBL] [Abstract][Full Text] [Related]
9. Focus on 16p13.3 Locus in Colon Cancer.
Mampaey E; Fieuw A; Van Laethem T; Ferdinande L; Claes K; Ceelen W; Van Nieuwenhove Y; Pattyn P; De Man M; De Ruyck K; Van Roy N; Geboes K; Laurent S
PLoS One; 2015; 10(7):e0131421. PubMed ID: 26222184
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
[TBL] [Abstract][Full Text] [Related]
11. Candidate driver genes in focal chromosomal aberrations of stage II colon cancer.
Brosens RP; Haan JC; Carvalho B; Rustenburg F; Grabsch H; Quirke P; Engel AF; Cuesta MA; Maughan N; Flens M; Meijer GA; Ylstra B
J Pathol; 2010 Aug; 221(4):411-24. PubMed ID: 20593488
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of lymphovascular invasion in colorectal cancer and its association with genomic alterations.
Jiang HH; Zhang ZY; Wang XY; Tang X; Liu HL; Wang AL; Li HG; Tang EJ; Lin MB
World J Gastroenterol; 2019 May; 25(20):2489-2502. PubMed ID: 31171892
[TBL] [Abstract][Full Text] [Related]
13. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
[TBL] [Abstract][Full Text] [Related]
15. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
16. Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma.
Yamamoto S; Midorikawa Y; Morikawa T; Nishimura Y; Sakamoto H; Ishikawa S; Akagi K; Aburatani H
Genes Chromosomes Cancer; 2010 May; 49(5):487-96. PubMed ID: 20175194
[TBL] [Abstract][Full Text] [Related]
17. DNA copy number aberrations associated with the clinicopathological features of colorectal cancers: Identification of genomic biomarkers by array-based comparative genomic hybridization.
Nakao M; Kawauchi S; Uchiyama T; Adachi J; Ito H; Chochi Y; Furuya T; Oga A; Sasaki K
Oncol Rep; 2011 Jun; 25(6):1603-11. PubMed ID: 21468551
[TBL] [Abstract][Full Text] [Related]
18. Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
Wang K; Song K; Ma Z; Yao Y; Liu C; Yang J; Xiao H; Zhang J; Zhang Y; Zhao W
Br J Cancer; 2020 Aug; 123(3):410-417. PubMed ID: 32435058
[TBL] [Abstract][Full Text] [Related]
19. Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrations.
Bruin SC; de Ronde JJ; Wiering B; Braaf LM; de Wilt JH; Vincent AD; van Velthuysen ML; Ruers TJ; Wessels LF; van't Veer LJ
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S560-9. PubMed ID: 23783809
[TBL] [Abstract][Full Text] [Related]
20. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
